Advertisement

Document › Details
Sofinnova Partners. (4/23/18). "Press Release: Armance Bordes Joins Sofinnova Partners as General Counsel". Paris.
![]() |
Organisation | Sofinnova Partners S.A.S. |
Group | Sofinnova (Group) | |
Organisation 2 | Sofinnova Crossover I fund | |
Group | Sofinnova (Group) | |
![]() |
Product | venture capital |
Product 2 | legal services | |
![]() |
Person | Bordes, Armance (Sofinnova 201804– General Counsel at Sofinnova Partners before Eurazeo + Gibson Dunn & Crutcher) |
Person 2 | Blanche, Christophe (Sofinnova 201612c– CFO at Sofinnova Partners) | |
Sofinnova Partners’ appointment of Armance Bordes strengthens the firm’s support team.
Sofinnova Partners, a leading European venture capital firm specialized in Life Sciences, has appointed Armance Bordes as General Counsel. In charge of the firm’s legal and regulatory affairs, Armance brings to Sofinnova Partners a ten-year experience in private equity.
Prior to joining Sofinnova Partners, Armance was Deputy General Counsel and Secretary of the board of directors at Eurazeo. She has supervised numerous investments and divestments in listed companies; she has been involved in particular in the IPOs of Elis and Europcar in which she has been a board member. Armance started her career as an M&A lawyer at Gibson Dunn & Crutcher, LLP in Paris. She graduated from the University of Paris I Panthéon -Sorbonne and holds a postgraduate diploma from Oxford University. She is admitted to the Paris bar.
As part of a growing support team headed by Monique Saulnier, Managing Partner & COO of Sofinnova Partners, Armance will work in close ties with Christophe Blanche, Chief Financial Officer since the end of 2016. Christophe joined the firm with a sixteen-year experience in private equity. He has worked as Chief Financial Officer in French and Luxembourg management companies, and prior to that as a senior audit manager in PricewaterhouseCoopers. Christophe is Réviseur d’Entreprises in Luxembourg and graduated from the Institut Supérieur du Commerce, a French business school.
Monique Saulnier, Managing Partner and COO of Sofinnova Partners, indicates: « We are delighted to welcome Armance in Sofinnova Partners’ support team. Her experience and acute understanding of the business is a major asset in a period of increased activity, with notably the launch of new funds such as Sofinnova Crossover I which announced a closing in April at €275 M ».
Sofinnova Partners’ support team today counts 13 people. Alongside Armance who heads legal and regulatory activity and Christophe Blanche who leads the finance and administrative activity, the support team is in charge of a diversified set of functions including Accounting Investors relations and reporting, Human Resources, IT and Deal Flow Management.
Press contact pour Sofinnova Partners
Anne Rein
anne.rein@strategiesimage.com
+33 (0) 6.03.35.92.05
Record changed: 2019-10-19 |
Advertisement
![Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px](/banner/iito-20190621-650-089-life-sciences-asia.jpg)
More documents for Sofinnova (Group)
- [1] Sofinnova Partners. (10/17/19). "Press Release: Sofinnova Partners Raises €333 Million Capital IX Early-stage Healthcare Fund". Paris....
- [2] Microphyt. (7/11/19). "Press Release: Microphyt Raises €28.5 Million to Develop Its Portfolio of Microalgae-based Natural Solutions for Nutrition and Well-being". Baillargues....
- [3] Karuna Therapeutics, Inc.. (4/1/19). "Press Release: Karuna Completes $80 Million Series B Financing". Boston, MA....
- [4] Polyneuron Pharmaceuticals AG. (3/28/19). "Press Release: Polyneuron Raises CHF22.5 Million in Series A to Advance Novel Therapies for Autoimmune Diseases". Basel....
- [5] Rgenix, Inc.. (10/9/18). "Press Release: Rgenix Raises $40M in Series C Funding To Support Clinical Stage Oncology Programs". New York, NY....
- [6] HotSpot Therapeutics, Inc.. (7/17/18). "Press Release: HotSpot Therapeutics Completes $45 Million Series A Financing to Advance New Approach to Allosteric Drug Discvovery". Cambridge, MA....
- [7] NodThera Ltd.. (6/25/18). "Press Release: NodThera Secures £28 Million ($40 Million) Series A Financing". Cambridge....
- [8] Sofinnova Partners. (5/21/18). "Press Release: Sofinnova Partners Appoints Dr. Martin T. Rothman as Venture Partner". Paris....
- [9] EryDel S.p.A.. (4/24/18). "Press Release: EryDel Raises Euro 26.5 Million in Financing. Sofinnova Partners Leads Erydel’s Financing". Bresso....
- [10] Sofinnova Partners. (4/16/18). "Press Release: LimFlow Raises €27 million ($33.5 million) in Series C Financing Led by Sofinnova Partners to Advance Innovative Critical Limb Ischemia (CLI) treatment". Paris....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top